Clinical trials
Completed COVID-19 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 19 |
| 2021 | 14 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 7 |
| ModernaTX, Inc. | 6 |
| Pfizer | 6 |
| AnGes, Inc. | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
| Gilead Sciences | 3 |
| Shionogi | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Takeda | 2 |
| Atea Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 49 |
| Coronavirus Infections | 6 |
| Virus Diseases | 4 |
| Influenza, Human | 2 |
| Severe Acute Respiratory Syndrome | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.